From a molecular drugstore perspective , Relafen 750 ( the drug) represents a significant case study. Its mechanism of inhibiting cyclooxygenase enzymes, particularly COX-2 , highlights the intricacies of pain control. The agent's therapeutic effect stems from alleviating prostaglandin production